Wang TD, Lee WJ, Shih FY, Huang CH, Chen WJ, Lee YT, et al. Association of epicardial adipose tissue with coronary atherosclerosis is region-specific and independent of conventional risk factors and intra-abdominal adiposity. Atherosclerosis 2010;213:279-87.
BettencourtN,ToschkeAM,LeiteD,RochaJ,CarvalhoM, .Sampaio 3, -
F, 2012.Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden,Int J Cardiol 158 26 -32
AlexopoulosN,McLeanDS,JanikM,ArepalliCD,StillmanAE,RaggiP, 2010.Epicardial adipose tissue and coronary artery plaque characteristics,Atherosclerosis 210 150 -4
OkaT,YamamotoH,OhashiN,KitagawaT,KunitaE,UtsunomiyaH, 2012.Association between epicardial adipose tissue volume and characteristics of non-calcified plaques assessed by coronary computed tomographic angiography,Int J Cardiol 161 45 -9
2009.,Nutr Metabol Cardiovasc Dis 19 211 -7
TaguchiR,TakasuJ,ItaniY,YamamotoR,YokoyamaK,WatanabeS, 2001.Pericardial fat accumulation in men as a risk factor for coronary artery disease,Atherosclerosis 157 203 -9
SacksHS,FainJN, 2007.Human epicardial adipose tissue: a review,Am Heart J 153 907 -17
MarchingtonJM,MattacksCA,PondCM, 1989.Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties,Comp Biochem Physiol B 94 225 -32
LongstrethGF,ThompsonWG,CheyWD,HoughtonLA,MearinF,SpillerRC, 2006.Functional bowel disorders,Gastroenterology 130 1480 -91
DrossmanDA,CamilleriM,MayerEA,WhiteheadWE, 2002.AGA technical review on irritable bowel syndrome,Gastroenterology 123 2108 -31
WestonAP,BiddleWL,BhatiaPS,MinerPB, 1993.Terminal ileal mucosal mast cells in irritable bowel syndrome,Dig Dis Sci 38 1590 -5
TornblomH,LindbergG,NybergB,VeressB, 2002.Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome,Gastroenterology 123 1972 -9
Rome F. Guidelines--Rome III Diagnostic, 2006.Criteria for Functional Gastrointestinal Disorders,J Gastrointestin Liver Dis 15 307 -12
IacobellisG,AssaelF,RibaudoMC,ZappaterrenoA,AlessiG,Di MarioU, 2003.Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction,Obes Res 11 304 -10
IacobellisG,RibaudoMC,AssaelF,VecciE,TibertiC,ZappaterrenoA, 2003.Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk,J Clin Endocrinol Metab 88 5163 -8
2000.,Neurogastroenterol Motil 12 449 -57
Bueno L, 2008.Protease activated receptor 2: a new target for IBS treatment,Eur Rev Med Pharmacol Sci 12 95 -102
2008.Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity,Gut 57 591 -9
GuilarteM,SantosJ,de TorresI,AlonsoC,VicarioM,RamosL, 2007.Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum,Gut 56 203 -9
2004.,Gastroenterology 126 693 -702
DinanTG,QuigleyEM,AhmedSM,ScullyP,O'Brien S,O'Mahony L, 2006.Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?,Gastroenterology 130 304 -11
2002.Activation of the mucosal immune system in irritable bowel syndrome,Gastroenterology 122 1778 -83
CremonC,GarganoL,Morselli-LabateAM,SantiniD,CogliandroRF,De GiorgioR, 2009.Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms,Am J Gastroenterol 104 392 -400
2006.Who left the door open?,Am J Gastroenterol 101 1295 -8
2012.,Am J Physiol Gastrointest Liver Physiol 303 G775 -85
BarbaraG,ZecchiL,BarbaroR,CremonC,BellacosaL,MarcelliniM, 2012.Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome,J Clin Gastroenterol 46 S52 -5
2008.Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats,Gut 57 582 -90
Am J Gastroenterol, 1998., 93 1311 -7
IacobellisG,WillensHJ, 2009.Echocardiographic epicardial fat: a review of research and clinical applications,J Am Soc Echocardiogr 22 1311 -9
MalavazosAE,ErmeticiF,CeredaE,ComanC,LocatiM,MorriconeL, .Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity, -
2008.,Nutr Metabol Cardiovasc Dis 18 523 -30
TamakoshiK,YatsuyaH,KondoT,HoriY,IshikawaM,ZhangH, 2003.The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic lowgrade inflammatory state,Int J Obes Relat Metab Disord 27 443 -9